Copyright © 1996, 2001 by Galen Daryl Knight
and VitaleTherapeutics, Inc.
Monooxygenase substrates distinctly different
from the vitaletheine modulators are known to be carcinogenic. It is unclear
at this time whether they block interactions of the vitaletheine modulators
("the right key") with the monooxygenase ("the lock"), or with other receptors
("locks"), or if they chemically react with or inactivate ("bend") these
important sulfur compounds so that they can no longer function properly
on their appropriate receptor ("lock").